Featured Research

from universities, journals, and other organizations

Clinical trial reveals pterostilbene reduces blood pressure in adults

Date:
September 20, 2012
Source:
University of Mississippi
Summary:
A form of pterostilbene, a compound found naturally in blueberries, reduces blood pressure in adults, according to new results.

Blueberries.
Credit: ฉ Alexstar / Fotolia

A form of pterostilbene, a compound found naturally in blueberries, reduces blood pressure in adults, according to results of a clinical trial presented Sept. 20 at the American Heart Association's 2012 Scientific Sessions on High Blood Pressure Research in Washington, D.C.

The randomized, double-blind, placebo-controlled study was conducted by University of Mississippi School of Pharmacy and School of Medicine researchers to determine whether pterostilbene (tero-STILL-bean), an ingredient being marketed as pTeroPureฎ, improves cardiovascular health.

Investigators evaluated the ingredient in 80 patients with high cholesterol (total cholesterol of 200 or greater and/or LDL cholesterol of 100 or greater). Twice daily for six to eight weeks, participants received either high (125 mg) doses of pterostilbene, low (50 mg) doses of pterostilbene, pterostilbene (50 mg) with grape extract (100 mg), or a placebo, said Daniel M. Riche, the study's principal investigator. Investigators assessed patients' blood pressure, body weight and blood lipids at the beginning and end of their participation in the study.

"We found reduced systolic and diastolic blood pressure in patients who received the high dose of pterostilbene and reduced systolic blood pressure in patients who received the low dose of pterostilbene with grape extract," said Riche, an assistant professor of pharmacy practice and medicine at the UM Medical Center in Jackson.

Participants in the high-dose pterostilbene group (250 mg per day) achieved significant reductions in blood pressure compared to placebo: 7.8 mmHg in systolic BP (p less than 0.01) and 7.3 mmHg in diastolic BP (p less than 0.001).

The only change in lipids was an increase in LDL cholesterol with pterostilbene (24.9 mg/dL, p less than 0.001), which was less among participants already on cholesterol-lowering medication and was not seen among those who also received the grape extract. Participants not on cholesterol medication also achieved a minor average reduction in body weight (reduced body mass index of 0.59 kg/m2) with pterostilbene; body weight did not change significantly compared to placebo for the other participants.

Patent rights covering the use of pterostilbene for various health benefits were licensed from UM for commercial development two years ago by the ChromaDex Corp., which is marketing it as pTeroPure, the key ingredient in BluScience™, a line of dietary supplements available in some 17,000 outlets across the country. The California-based company provided support to the university for its yearlong clinical study (http://clinicaltrials.gov identifier NCT 01267227).

"We are pleased that the University of Mississippi Medical Center conducted our first human study, which was a key to us and our commitment to providing clinical proof for our ingredients," said Frank Jaksch Jr., CEO and co-founder of ChromaDex. "This is an important milestone for us in adding credibility to our products for further market expansion opportunities."

Along with Dr. Marion Wofford, professor of medicine, the study's co-investigators include Justin J. Sherman, associate professor of pharmacy practice; Michael E. Griswold, director of UMMC's Center for Biostatistics; and Krista D. Riche, clinical pharmacy specialist at St. Dominic Hospital in Jackson.

"We are pleased to work with ChromaDex to explore the potential of this dietary supplement ingredient to improve the health and well-being of people in the U.S. and around the globe," said School of Pharmacy Dean David D. Allen.

ChromaDex is a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. The company is committed to sustainable "green chemistry" and provides dietary supplement, food, beverage, nutraceutical and cosmetic industries with novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards.


Story Source:

The above story is based on materials provided by University of Mississippi. Note: Materials may be edited for content and length.


Cite This Page:

University of Mississippi. "Clinical trial reveals pterostilbene reduces blood pressure in adults." ScienceDaily. ScienceDaily, 20 September 2012. <www.sciencedaily.com/releases/2012/09/120920141008.htm>.
University of Mississippi. (2012, September 20). Clinical trial reveals pterostilbene reduces blood pressure in adults. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2012/09/120920141008.htm
University of Mississippi. "Clinical trial reveals pterostilbene reduces blood pressure in adults." ScienceDaily. www.sciencedaily.com/releases/2012/09/120920141008.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) — A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) — The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) — The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) — Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:  

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile iPhone Android Web
          Follow Facebook Twitter Google+
          Subscribe RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins